- Filed
- Feb 21, 2024 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Feb 18, 2024 | 1.38B sh |
| Stock Repurchased | Q3 2024 · Dec 31, 2023 | −$44.06K |
| Stock Repurchased | Q3 2024 · Dec 31, 2022 | $50.28K |
| Operating Cash Flow | Q3 2024 · Dec 31, 2023 | −$1.37M |
| Operating Cash Flow | Q3 2024 · Dec 31, 2022 | −$1.16M |
| Stockholders Equity | Q3 2024 · Dec 31, 2023 | −$1.35M |
| Stockholders Equity | Q3 2024 · Mar 31, 2023 | $10.1M |
| Stockholders Equity | Q3 2024 · Dec 31, 2022 | $10.24M |
| Stockholders Equity | Q3 2024 · Mar 31, 2022 | $11.06M |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $1.36M |
| Current Liabilities | Q3 2024 · Mar 31, 2023 | $2.13M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $1.36M |
| Total Liabilities | Q3 2024 · Mar 31, 2023 | $2.28M |
| Total Liabilities | Q3 2024 · May 28, 2021 | $389.72K |
| Current Assets | Q3 2024 · Dec 31, 2023 | $3.59K |
| Current Assets | Q3 2024 · Mar 31, 2023 | $237.18K |
| Total Assets | Q3 2024 · Dec 31, 2023 | $3.59K |
| Total Assets | Q3 2024 · Mar 31, 2023 | $12.38M |
| Sga Expense | Q3 2024 · Dec 31, 2023 | $23.73K |
| Sga Expense | Q3 2024 · Dec 31, 2023 | $49.14K |
| Sga Expense | Q3 2024 · Dec 31, 2022 | −$27.89K |
| Sga Expense | Q3 2024 · Dec 31, 2022 | $28.93K |
| Rd Expense | Q3 2024 · Dec 31, 2023 | $2.88K |
| Rd Expense | Q3 2024 · Dec 31, 2023 | $2.88K |
| Rd Expense | Q3 2024 · Dec 31, 2022 | $41.09K |
| Net Income | Q3 2024 · Dec 31, 2023 | −$2.01M |
| Net Income | Q3 2024 · Dec 31, 2023 | −$2.87M |
| Net Income | Q3 2024 · Dec 31, 2022 | −$534.79K |
| Net Income | Q3 2024 · Dec 31, 2022 | −$1.72M |
| Operating Income | Q3 2024 · Dec 31, 2023 | −$1.11M |
| Operating Income | Q3 2024 · Dec 31, 2023 | −$1.83M |
| Operating Income restated | Q3 2024 · Dec 31, 2022 | −$540.62K |
| Operating Income restated | Q3 2024 · Dec 31, 2022 | −$1.82M |